Navigation Links
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain
Date:12/7/2009

Nutra Pharma has completed submission of the final Nyloxin OTC and Nyloxin Rx packaging and labeling to the Food and Drug Administration (FDA). This registration is considered the final step required by the FDA to begin selling Nyloxin OTC and Nyloxin Rx in the United States for the treatment of chronic pain.

Plantation, FL (Vocus) December 7, 2009 -- Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted the final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Nyloxin OTC, an over-the-counter treatment for moderate to severe (Stage 2) chronic pain, and Nyloxin Rx, a prescription treatment for severe (Stage 3) chronic pain.

“Completing the FDA registration for Nyloxin OTC and Nyloxin Rx is an important and required step towards introducing our Nyloxin-branded pain relievers throughout domestic and international markets,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma. “With the FDA registration now completed, we plan to immediately move forward with our launch of Nyloxin Rx here in the United States, while we finalize our international drug registrations in Canada, Europe and South America for both our prescription and over-the-counter formulations,” he concluded.

The Company first introduced Nyloxin OTC in November as a treatment for moderate to severe (Stage 2) chronic pain. Nyloxin OTC is similar to the Company’s recently launched pain reliever, Cobroxin, and will be available internationally as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Additionally, the Company introduced Ny
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain
2. Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks
3. Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution
4. Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
5. Vivakor Presents at Nutraceutical Event
6. Reportlinker Adds US World Nutraceutical Ingredients Industry
7. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
8. Star Scientific Files Second Quarter Financial Results; Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and Viability of Active Components for a Non-Nicotine Nutraceutical (CigRx(TM))
9. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
10. NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract
11. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain
(Date:8/27/2014)... Ellen V. Krieger, DDS released a new ... video is meant to describe the business and industry best ... over 28 years of cosmetic and family dentistry experience, Dr ... patients feel welcomed and cared for. , Dr. Krieger has ... years, building a solid reputation of offering bright, friendly service ...
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... Media Meetup event in collaboration with Diabetes Community Advocacy ... on October 24-25, 2014 at Embassy Suites LAX ... “DiabetesSisters’ Social Media Meetup featuring DSMA Live”, an event ... on Friday evening, October 24th. , Interactive in many ...
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 ... management, governance, and compliance software solutions for next-generation ... made Inc. magazine’s Inc. 500|5000, an exclusive ranking ... fifth consecutive year. AvePoint joins brands such as ... the 2014 edition. , This underscores continued ...
(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... announced on August 1, that Organic Raw Carob Powder ... is recalled due to possible contamination with ... people with weakened immune systems. In healthy people it ...
Breaking Medicine News(10 mins):Health News:Ellen V. Krieger, DDS of McLean, Virginia Announces New Video Describing Industry Best Practices 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 3Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... Daiichi Sankyo, Inc. and Eli Lilly and ... the U.S. Food and Drug Administration (FDA) approved Effient(TM) ... (including stent thrombosis) in patients with acute coronary syndromes ... percutaneous coronary intervention (PCI). PCI usually includes the ...
... tip the scales toward more health risks, researcher says , FRIDAY, ... night, make you snap at your spouse and children, and make ... can also make you gain weight -- especially if you,re overweight ... people out, and stress has been linked to a number of ...
... a bi-national team of global health researchers at the University ... among male clients of female sex workers in Tijuana, has ... unprotected sex. They also reported a high prevalence of ... is necessary to prevent the spread of HIV and other ...
... ecological study of its kind in the world, a Wake ... finding that groundwater and airborne manganese in North Carolina correlates ... ... County in North Carolina: An Ecological Study," was published online ...
... July 10 Compirion Healthcare Solutions, a whole-hospital process improvement ... to help educate hospital executives, managers and clinicians in strategies for ... be found at www.compirion.com/webinars along with times, ... entitled Achieving Early AM Hospital Discharges: ...
... , WASHINGTON, July 10 The Department of Veterans ... design and build a free-standing spinal cord injury center ... The contract was awarded to the C3T Construction Company ... building will have a connecting tunnel, providing access to ...
Cached Medicine News:Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 2Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 3Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 4Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 5Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 6Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 7Health News:Job Stress, Economy Weighing on Americans 2Health News:Risky sexual behavior among male clients of Tijuana sex workers heightens risk of HIV transmission 2Health News:Environmental manganese good in trace amounts but can correlate to cancer rates 2Health News:Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 2Health News:Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 3
(Date:8/26/2014)... Aug. 26, 2014 Research and ... "Global Veterinary Diagnostics Market 2014-2018" report ... include various tests, which are used to detect ... and biomedical researchers are mainly availing these diagnostic ... Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, and hematology. ...
(Date:8/26/2014)... 2014 Using publicly released 2015 rate filings ... for five common specialty drugs. Specialty drugs have ... high costs and shortage of generic alternatives. They ... prescription, and are used for a broad variety ... HealthPocket found that among 2015 ...
(Date:8/26/2014)... , Aug. 26, 2014  Sorrento Therapeutics, ... late-stage clinical oncology company developing new treatments for ... it has received funding to advance an immunotherapy ... treatment of IPF, which affects more than 100,000 ... lungs increases and patients gradually lose the ability ...
Breaking Medicine Technology:Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 32015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3
... Maine, July 14, 2011 IDEXX Laboratories, Inc. (Nasdaq: ... its 2011 second quarter financial results for Friday, July ... conduct an analyst conference call beginning at 9:00 a.m. ... Individuals can access a live Webcast of the ...
... Biomedical Corporation (OTCBB:QTXB), an emerging leader in the ... on its patented technology platforms for the worldwide ... the lawsuit with NURX, its prior Joint Venture ... operations to expand its over-the-counter products and laboratory ...
Cached Medicine Technology:QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products 2QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products 3
... Bio-Modular total shoulder system is ... use in both hemiarthroplasty and ... Modularity in combination with a ... component options provide the surgeon ...
...
...
... Knee employs titanium alloy plasma spray ... fixation surface. Biomet's ArCom processed polyethylene ... proven bearing material. The Maxim Knee ... Modular tibial components offer excellent sizing ...
Medicine Products: